» Articles » PMID: 29794601

HIV, HCV, HBV, and Syphilis Among Transgender Women from Brazil: Assessing Different Methods to Adjust Infection Rates of a Hard-to-reach, Sparse Population

Abstract

Different sampling strategies, analytic alternatives, and estimators have been proposed to better assess the characteristics of different hard-to-reach populations and their respective infection rates (as well as their sociodemographic characteristics, associated harms, and needs) in the context of studies based on respondent-driven sampling (RDS). Despite several methodological advances and hundreds of empirical studies implemented worldwide, some inchoate findings and methodological challenges remain. The in-depth assessment of the local structure of networks and the performance of the available estimators are particularly relevant when the target populations are sparse and highly stigmatized. In such populations, bottlenecks as well as other sources of biases (for instance, due to homophily and/or too sparse or fragmented groups of individuals) may be frequent, affecting the estimates.In the present study, data were derived from a cross-sectional, multicity RDS study, carried out in 12 Brazilian cities with transgender women (TGW). Overall, infection rates for HIV and syphilis were very high, with some variation between different cities. Notwithstanding, findings are of great concern, considering the fact that female TGW are not only very hard-to-reach but also face deeply-entrenched prejudice and have been out of the reach of most therapeutic and preventive programs and projects.We cross-compared findings adjusted using 2 estimators (the classic estimator usually known as estimator II, originally proposed by Volz and Heckathorn) and a brand new strategy to adjust data generated by RDS, partially based on Bayesian statistics, called for the sake of this paper, the RDS-B estimator. Adjusted prevalence was cross-compared with estimates generated by non-weighted analyses, using what has been called by us a naïve estimator or rough estimates.

Citing Articles

Acceptability and completeness of vaccination schedules recommended for transgender women and travestis in the city of São Paulo, Brazil: a cross-sectional study, 2019-2020.

Martins C, Bassichetto K, Veras M Epidemiol Serv Saude. 2025; 33(spe1):e2024341.

PMID: 39813582 PMC: 11734595. DOI: 10.1590/S2237-96222024v33e2024341.especial.en.


Mapping of the trans population in the Baixada Santista region, Brazil, 2023: a descriptive study.

Barroso B, Bassichetto K, Vieira D, Gois I, Rodrigues J, Santos N Epidemiol Serv Saude. 2025; 33(spe1):e2024409.

PMID: 39813456 PMC: 11734653. DOI: 10.1590/S2237-96222024v33e2024409.especial.en.


Factors associated with the completion of syphilis treatment among transgender women and travestis, in five Brazilian capitals, 2019-2021: a multicenter cross-sectional study.

Carreira L, Veras M, Benzaken A, Queiroz R, Silveira E, Oliveira E Epidemiol Serv Saude. 2024; 33(spe1):e2024294.

PMID: 39661781 PMC: 11654392. DOI: 10.1590/S2237-96222024v33e2024294.especial.en.


Preparing for the Implementation of Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis Within the Brazilian Public Health System (ImPrEP CAB Brasil): Qualitative Study.

Pimenta M, Torres T, Hoagland B, Cohen M, Mann C, Jalil C JMIR Public Health Surveill. 2024; 10:e60961.

PMID: 39446416 PMC: 11544328. DOI: 10.2196/60961.


Prevalence of hepatitis among young men who have sex with men and transgender women in Brazil.

Santos C, Leite B, Lima F, Magno L, Grangeiro A, Westin M Rev Saude Publica. 2024; 58(suppl 1):4s.

PMID: 39417514 PMC: 11573373. DOI: 10.11606/s1518-8787.2020054005555.


References
1.
Khan S, Hussain M, Parveen S, Bhuiyan M, Gourab G, Sarker G . Living on the extreme margin: social exclusion of the transgender population (hijra) in Bangladesh. J Health Popul Nutr. 2009; 27(4):441-51. PMC: 2928103. DOI: 10.3329/jhpn.v27i4.3388. View

2.
Silva-Santisteban A, Eng S, de la Iglesia G, Falistocco C, Mazin R . HIV prevention among transgender women in Latin America: implementation, gaps and challenges. J Int AIDS Soc. 2016; 19(3 Suppl 2):20799. PMC: 4949309. DOI: 10.7448/IAS.19.3.20799. View

3.
Reisner S, Poteat T, Keatley J, Cabral M, Mothopeng T, Dunham E . Global health burden and needs of transgender populations: a review. Lancet. 2016; 388(10042):412-436. PMC: 7035595. DOI: 10.1016/S0140-6736(16)00684-X. View

4.
Goel S, Salganik M . Respondent-driven sampling as Markov chain Monte Carlo. Stat Med. 2009; 28(17):2202-29. PMC: 3684629. DOI: 10.1002/sim.3613. View

5.
Wilson E, Garofalo R, Harris R, Herrick A, Martinez M, Martinez J . Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work. AIDS Behav. 2009; 13(5):902-13. PMC: 2756328. DOI: 10.1007/s10461-008-9508-8. View